Bio-Rad Laboratories (BIO) Net Margin (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Net Margin data on file, last reported at 89.02% in Q1 2026.

• Net Margin for Q1 2026 came in at 89.02%, down 9995.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.52% (up 9168.0% YoY), and the FY2025 annual result was 29.42%, up 10127.0% from the prior year.
• Net Margin fell to 89.02% in Q1 2026 per BIO's latest filing, from 103.87% in the prior quarter.
• Over five years, Net Margin peaked at 113.35% in Q4 2022 and troughed at 480.98% in Q1 2022.
• A 5-year average of 51.68% and a median of 10.19% in 2023 frame the typical range for Net Margin.
• The sharpest annual moves came in 2022 and 2023: Net Margin sank 61546 bps in 2022, then jumped 49117 bps in 2023.
• A 5-year view of Net Margin shows it stood at 113.35% in 2022, then slumped by 55 bps to 51.34% in 2023, then sank by 309 bps to 107.24% in 2024, then jumped by 197 bps to 103.87% in 2025, then plunged by 186 bps to 89.02% in 2026.
• Business Quant data shows BIO's Net Margin at 89.02% in Q1 2026, 103.87% in Q4 2025, and 52.36% in Q3 2025.